Institutional shares held 218 Million
341K calls
151K puts
Total value of holdings $17.6B
$27.5M calls
$12.2M puts
Market Cap $20.2B
249,652,992 Shares Out.
Institutional ownership 87.42%
# of Institutions 742


Latest Institutional Activity in HOLX

Top Purchases

Q3 2024
Swedbank Ab Shares Held: 1.94M ($157M)
Q3 2024
Congress Asset Management CO Shares Held: 1.35M ($109M)
Q3 2024
Allspring Global Investments Holdings, LLC Shares Held: 297K ($24M)
Q3 2024
Robeco Institutional Asset Management B.V. Shares Held: 267K ($21.6M)
Q3 2024
Claro Advisors LLC Shares Held: 27.5K ($2.22M)

Top Sells

Q3 2024
Assenagon Asset Management S.A. Shares Held: 384K ($31M)
Q3 2024
Sg Americas Securities, LLC Shares Held: 20.1K ($1.63M)
Q3 2024
Wedge Capital Management L L P Shares Held: 457K ($36.9M)
Q3 2024
New York State Common Retirement Fund Shares Held: 136K ($11M)
Q3 2024
State Of Alaska, Department Of Revenue Shares Held: 189K ($15.3M)

About HOLX

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.


Insider Transactions at HOLX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
304K Shares
From 24 Insiders
Grant, award, or other acquisition 133K shares
Exercise of conversion of derivative security 170K shares
Sell / Disposition
427K Shares
From 20 Insiders
Open market or private sale 238K shares
Payment of exercise price or tax liability 107K shares
Bona fide gift 81.9K shares

Track Institutional and Insider Activities on HOLX

Follow HOLOGIC INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HOLX shares.

Notify only if

Insider Trading

Get notified when an Hologic Inc insider buys or sells HOLX shares.

Notify only if

News

Receive news related to HOLOGIC INC

Track Activities on HOLX